Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Dana-Farber, Roche, Canon, Qiagen, Win US Patents


The Dana-Farber Cancer Institute has been awarded US Patent No. 8,623,603, "Full cold-PCR enrichment with reference blocking sequence."

Gerassimos Makrigiorgos is named as the inventor.

Roche Diagnostics has been awarded US Patent No. 8,623,602, "Lysis and reverse transcription for mRNA quantification."

Michael Kubista, Linda Stroembom, and Neven Zoric are named as inventors.

Canon has been awarded US Patent No. 8,623,637, "Nucleic acid amplification apparatus and thermal cycler."

Ikumasa Ikeda is named as the inventor.

Qiagen has been awarded US Patent No. 8,624,020, "Method for isolating and purifying nucleic acids."

Ralf Himmelreich and Sabine Werner are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.